Cell therapy’s next chapter: Industry embraces in-vivo innovation Nikhil C Bhanumathi Sep 15, 2025 Nikhil C Bhanumathi, Principal Clinical Lead, Thermo Fisher Scientific highlights that Cell therapy is entering a bold new phase…
ImmunoACT to lead journey of indigenous CAR-T cell therapy in India but market access a hurdle:… EP News Bureau Nov 1, 2023 As per ImmunoACT CEO, NexCAR19 will be available at a price of Rs 30-40 lakh ($36,000- $48,000), which is 1/10th of the cost of…
Cell therapy for solid tumors may get approval by 2022: GlobalData EP News Bureau May 1, 2021 A total of 298 industry-sponsored trials are currently ongoing investigating cell therapies in non-haematological cancers, says…
